Literature DB >> 8455108

The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.

G L Brotzman1, D H Mark.   

Abstract

OBJECTIVE: To determine the effect on resident attitudes of policies regarding pharmaceutical representative interactions with residents.
DESIGN: Cross-sectional survey.
SETTING: National sample of U.S. family medicine residencies. PARTICIPANTS: Three hundred seventy-eight residents from 14 randomly selected programs. Seven programs had written policies and restrictions (restricted programs), and seven had no such restriction or guideline (free programs).
MEASUREMENTS AND MAIN RESULTS: The authors assessed resident attitudes regarding the perception of benefit from pharmaceutical representative activities, the usefulness of various sources of drug information, and the appropriateness of accepting gifts from a pharmaceutical representative. There were 265/378 respondents (70% response rate). Residents from restricted programs reported fewer benefits from pharmaceutical representative interactions and were less likely to feel that acceptance of gifts was appropriate. The amount of exposure to pharmaceutical representatives was positively correlated with perceived benefit and negatively correlated with ratings of appropriateness of gift acceptance.
CONCLUSION: Regulatory policies can influence resident attitudes and perceptions. Training programs should develop written policies to help guide resident-pharmaceutical representative interactions.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1993        PMID: 8455108     DOI: 10.1007/bf02599757

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

1.  Policies regulating the activities of pharmaceutical representatives in residency programs.

Authors:  G L Brotzman; D H Mark
Journal:  J Fam Pract       Date:  1992-01       Impact factor: 0.493

2.  Pharmaceutical representatives.

Authors:  L Scarpinato
Journal:  J Gen Intern Med       Date:  1991 Mar-Apr       Impact factor: 5.128

3.  Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.

Authors:  W P McKinney; D L Schiedermayer; N Lurie; D E Simpson; J L Goodman; E C Rich
Journal:  JAMA       Date:  1990-10-03       Impact factor: 56.272

4.  Gifts to physicians from industry.

Authors: 
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

5.  Pharmaceutical funding and medical students.

Authors:  T Mick
Journal:  JAMA       Date:  1991-02-06       Impact factor: 56.272

6.  Physicians and the pharmaceutical industry. American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

7.  Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.

Authors:  N Lurie; E C Rich; D E Simpson; J Meyer; D L Schiedermayer; J L Goodman; W P McKinney
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

8.  Drug promotion in a family medicine training center.

Authors:  A F Shaughnessy
Journal:  JAMA       Date:  1988-08-19       Impact factor: 56.272

9.  Undesirable marketing practices in the pharmaceutical industry.

Authors:  K Miller; W A Gouveia; M Barza; K Bower; L Curtis; E L Decker; H Dorkin; M Estes; W Mackey; D Marchbein
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

10.  Doctors, drug companies, and gifts.

Authors:  M M Chren; C S Landefeld; T H Murray
Journal:  JAMA       Date:  1989 Dec 22-29       Impact factor: 56.272

  10 in total
  11 in total

1.  Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.

Authors:  James S Yeh; Kirsten E Austad; Jessica M Franklin; Susan Chimonas; Eric G Campbell; Jerry Avorn; Aaron S Kesselheim
Journal:  J Grad Med Educ       Date:  2015-12

2.  Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

Authors:  James L Wofford; Christopher A Ohl
Journal:  BMC Med Educ       Date:  2005-02-08       Impact factor: 2.463

Review 3.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

4.  Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.

Authors:  G Guyatt
Journal:  Can Fam Physician       Date:  1997-11       Impact factor: 3.275

5.  Free gifts: redundancy or conundrum?

Authors:  A D So
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

6.  Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.

Authors:  Amie C O'Donoghue; Vanessa Boudewyns; Kathryn J Aikin; Emily Geisen; Kevin R Betts; Brian G Southwell
Journal:  J Health Commun       Date:  2015-07-15

7.  Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.

Authors:  Sayaka Saito; Kei Mukohara; Seiji Bito
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

8.  The "PharmFree" campaign: educating medical students about industry influence.

Authors:  Yavar Moghimi
Journal:  PLoS Med       Date:  2006-01-31       Impact factor: 11.069

9.  Chronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.

Authors:  Sayaka Saito; Kei Mukohara; Yasushi Miyata
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

10.  Characteristics and impact of drug detailing for gabapentin.

Authors:  Michael A Steinman; G Michael Harper; Mary-Margaret Chren; C Seth Landefeld; Lisa A Bero
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.